Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence.

Active surveillance for low-risk PTC has shown its safety and feasibility in certain populations. In the future, it is warranted to determine valuable tumor progression predictors and most suitable PTC patients for AS.